Suppr超能文献

使用[F]氟化钠正电子发射断层显像/计算机断层扫描(PET/CT)进行骨形成的位点特异性测量。

Site specific measurements of bone formation using [F] sodium fluoride PET/CT.

作者信息

Blake Glen M, Puri Tanuj, Siddique Musib, Frost Michelle L, Moore Amelia E B, Fogelman Ignac

机构信息

Biomedical Engineering Department, King's College London, Strand, LondonUK.

Department of Radiology, Royal Marsden Hospital, Sutton, Surrey, UK.

出版信息

Quant Imaging Med Surg. 2018 Feb;8(1):47-59. doi: 10.21037/qims.2018.01.02.

Abstract

Dynamic positron emission tomography (PET) imaging with fluorine-18 labelled sodium fluoride ([F]NaF) allows the quantitative assessment of regional bone formation by measuring the plasma clearance of fluoride to bone at any site in the skeleton. Today, hybrid PET and computed tomography (CT) dual-modality systems (PET/CT) are widely available, and [F]NaF PET/CT offers a convenient non-invasive method of studying bone formation at the important osteoporotic fracture sites at the hip and spine, as well as sites of pure cortical or trabecular bone. The technique complements conventional measurements of bone turnover using biochemical markers or bone biopsy as a tool to investigate new therapies for osteoporosis, and has a potential role as an early biomarker of treatment efficacy in clinical trials. This article reviews methods of acquiring and analyzing dynamic [F]NaF PET/CT scan data, and outlines a simplified approach combining venous blood sampling with a series of short (3- to 5-minute) static PET/CT scans acquired at different bed positions to estimate [F]NaF plasma clearance at multiple sites in the skeleton with just a single injection of tracer.

摘要

使用氟 - 18标记的氟化钠([F]NaF)进行动态正电子发射断层扫描(PET)成像,可通过测量氟化物向骨骼的血浆清除率来定量评估骨骼任何部位的局部骨形成。如今,PET与计算机断层扫描(CT)的双模态系统(PET/CT)已广泛应用,[F]NaF PET/CT提供了一种便捷的非侵入性方法,用于研究髋部和脊柱等重要骨质疏松性骨折部位以及纯皮质骨或小梁骨部位的骨形成。该技术补充了使用生化标志物或骨活检进行骨转换的传统测量方法,作为研究骨质疏松症新疗法的工具,并且在临床试验中作为治疗效果的早期生物标志物具有潜在作用。本文回顾了获取和分析动态[F]NaF PET/CT扫描数据的方法,并概述了一种简化方法,该方法结合静脉血采样与在不同床位位置采集的一系列短(3至5分钟)静态PET/CT扫描,仅通过一次注射示踪剂即可估计骨骼多个部位的[F]NaF血浆清除率。

相似文献

1
Site specific measurements of bone formation using [F] sodium fluoride PET/CT.
Quant Imaging Med Surg. 2018 Feb;8(1):47-59. doi: 10.21037/qims.2018.01.02.
2
Imaging of site specific bone turnover in osteoporosis using positron emission tomography.
Curr Osteoporos Rep. 2014 Dec;12(4):475-85. doi: 10.1007/s11914-014-0231-2.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Correlation between F-Sodium Fluoride positron emission tomography and bone histomorphometry in dialysis patients.
Bone. 2020 May;134:115267. doi: 10.1016/j.bone.2020.115267. Epub 2020 Feb 11.
5
7
Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Radiographics. 2014 Sep-Oct;34(5):1295-316. doi: 10.1148/rg.345130061.
9
Dissociation between global markers of bone formation and direct measurement of spinal bone formation in osteoporosis.
J Bone Miner Res. 2004 Nov;19(11):1797-804. doi: 10.1359/JBMR.040818. Epub 2004 Aug 23.

引用本文的文献

2
The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring.
Front Pharmacol. 2025 Apr 28;16:1594903. doi: 10.3389/fphar.2025.1594903. eCollection 2025.
3
Osteoporosis treatment: current drugs and future developments.
Front Pharmacol. 2024 Aug 12;15:1456796. doi: 10.3389/fphar.2024.1456796. eCollection 2024.
4
Predicting Fractures Using Vertebral 18F-NaF Uptake in Prostate Cancer Patients.
J Bone Metab. 2023 Nov;30(4):329-337. doi: 10.11005/jbm.2023.30.4.329. Epub 2023 Nov 30.
5
Bone Turnover Markers: Basic Biology to Clinical Applications.
Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.
8
[F] Sodium Fluoride PET Kinetic Parameters in Bone Imaging.
Tomography. 2021 Dec 1;7(4):843-854. doi: 10.3390/tomography7040071.

本文引用的文献

1
18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer.
Oncotarget. 2017 May 30;8(22):36001-36011. doi: 10.18632/oncotarget.16418.
2
Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18.
3
The Role of 18F-Sodium Fluoride PET/CT Bone Scans in the Diagnosis of Metastatic Bone Disease from Breast and Prostate Cancer.
J Nucl Med Technol. 2016 Dec;44(4):217-222. doi: 10.2967/jnmt.116.176859. Epub 2016 Sep 15.
4
Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.
Curr Osteoporos Rep. 2016 Aug;14(4):115-25. doi: 10.1007/s11914-016-0312-5.
6
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET Registry.
J Nucl Med. 2015 Feb;56(2):222-8. doi: 10.2967/jnumed.114.150391. Epub 2015 Jan 15.
7
Newer PET application with an old tracer: role of 18F-NaF skeletal PET/CT in oncologic practice.
Radiographics. 2014 Sep-Oct;34(5):1295-316. doi: 10.1148/rg.345130061.
9
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET Registry.
J Nucl Med. 2014 Apr;55(4):574-81. doi: 10.2967/jnumed.113.130005. Epub 2014 Feb 27.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验